Journal
RSC ADVANCES
Volume 10, Issue 40, Pages 23675-23681Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0ra03659e
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research (CIHR)
- Ministry of Economic Development, Job Creation and Trade
- Natural Sciences and Engineering Research Council of Canada
Ask authors/readers for more resources
We report the development and use of a light-mediatedin situgrafting technology for the surface modification of biosynthetic corneal implants with peptide-capped nanoparticles (15-65 nm). The resulting materials have antimicrobial properties in bacterial suspension and also reduced the extent of biofilm formation. Ourin situgrafting technology offers a rapid route for the introduction of antimicrobial properties to premoulded corneal implants, and potentially other soft implant targets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available